TVPills

Sanofi/Regeneron Drugs Advertised on TV

2 prescription medications from Sanofi/Regeneron seen in TV advertising, with an estimated $455M in combined annual ad spend. Ranked by ad spend.

Share
US Dupixent

dupilumab · Eczema, asthma, nasal polyps

$390M CostDetails
CA Dupixent

dupilumab · Eczema, asthma, nasal polyps

$65M CostDetails

Frequently asked questions

What drugs does Sanofi/Regeneron advertise on TV?

Dupixent, Dupixent are among the Sanofi/Regeneron medications TVPills tracks in TV advertising — 2 in total.

Which Sanofi/Regeneron drug spends the most on TV advertising?

Dupixent (dupilumab) leads Sanofi/Regeneron's TV-advertised lineup with an estimated $390M in annual ad spend.

What conditions do Sanofi/Regeneron drugs treat?

The Sanofi/Regeneron drugs we track are advertised for Autoimmune.

Is a Sanofi/Regeneron drug right for me?

TVPills is an informational reference, not medical advice. Only a licensed healthcare provider can recommend whether a Sanofi/Regeneron medication is right for your situation.

TVPills

A reference tool to help identify prescription medications and supplements seen in television advertising. This is not medical advice. Always consult a healthcare professional.

TVPills is independent and not affiliated with, endorsed by, or sponsored by any drug manufacturer or brand. All trademarks are the property of their respective owners. Some links are affiliate links; we may earn a commission at no extra cost to you.